Free-residue Nutrients for the Bowel Preparation of Colon Capsule Endoscopy
1 other identifier
interventional
62
0 countries
N/A
Brief Summary
Colon capsule endoscopy(CCE) is a new diagnostic method of colonic lesions.It has advantages of no requirement for sedation and air insufflation.The bowel preparation has a closely relationship with yield of diagnosing diseases.Bowel preparation of CCE is not only to clean the colon but also to promote capsule propulsion.Now there is not an optimal method for CCE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2014
Longer than P75 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 20, 2016
CompletedFirst Posted
Study publicly available on registry
September 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFebruary 7, 2017
February 1, 2017
3.5 years
August 20, 2016
February 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bowel Cleansing Level of Two Different Bowel Preparation Methods
The first 32 patients adopted a low fiber diet two days before the CCE procedure. Bowel preparation included the ingestion of 2L polyethyleneglycol in the evening before test day and 2L PEG in the morning on the test day. The subsequent 30 patients were received free-residue Nutrients。Then they ingested 2L PEG between 5:00 and 7.00 am of the examination day. The capsule was scheduled at 8:30 am. When the capsule reached the small bowel, 0.75L PEG was used as first booster. If the capsule had not been excreted 3 hours later, the patients was received 0.5L PEG.
an expected average of 1 months from study procedure
Secondary Outcomes (4)
Accuracy parameters:assessment the yield of detection of polyps ≥6mm and ≥10mm;
an expected average of 1 months from study procedure
The gastrointestinal tract transit times and the colonic transit times between two different bowel preparation methods for CCE;
an expected average of 1 months from study procedure
Colon capsule excretion rate between two different bowel preparation methods;
an expected average of 1 months from study procedure
Adverse events between two different bowel preparation methods.
the PillCam procedure day
Study Arms (2)
Free-residue nutrients+PEG
EXPERIMENTALDiet: Free-residue nutrients Free-residue nutrient will be given when the patients are hungry before the two days of the capsule day.There are no other diet in this arm. Drug: PEG 2L PEG are used at 05:00-07:00 the morning of the test. Drug: Mosapride citrate The patients will take 5mg mosapride citrate at 8:00. Drug:PEG 0.75L and 0.50L PEG are administered as boosters for patients. Procedure: Colon capsule endoscopy The colon capsule will be ingested at 08:30 the day of the test.The images will be reviewed by two experienced endoscopists. Procedure: Colonoscopy On the following day of the test.All participants will undergo therapeutic colonoscopy.
Low fiber diet+PEG
EXPERIMENTALDiet: Low fiber diet Before the two days of the capsule day,when the patients hungry,low fiber diet wiil be given. Drug: PEG 4L PEG are used at 21:00-23:00 the night before the test and 05:00-07:00 the morning of the test. Drug: Mosapride citrate The patients will take 5mg mosapride citrate at 8:00. Drug:PEG 0.75L and 0.50L PEG are administered as boosters for patients. Procedure: Colon capsule endoscopy The colon capsule will be ingested at 08:30 the day of the test.The images will be reviewed by two experienced endoscopists. Procedure: Colonoscopy On the following day of the test,All participants will undergo therapeutic colonoscopy.
Interventions
This trial evaluated the efficiency of free-residue nutrients for the bowel prepartion of CCE.
Low fiber diet often used in the bowel prepartion of CCE. In this study, it is the control group.
In the study,all patients should undergo two colonoscopies.The first is for examinations and the second for therapy.
2L PEG are laxatives for experiment group.
4L PEG are laxatives in the control group.
These PEG are for boosters. All patients will take 0.75L and 0.5L PEG for two boosters.
5mg mosapride citrate are used to promote gastric motivity.
Eligibility Criteria
You may qualify if:
- years of age.
- underwent a diagnostic OC that demonstrated colorectal polyps that required endoscopic treatment.
You may not qualify if:
- dysphagia/swallowing disorder
- prior major abdominal surgery of the gastrointestinal tract, known or suspected bowel obstruction
- cardiac pacemaker/implanted electromedical device
- pregnant or nursing women
- any allergy or contraindication to the drugs used in the study.
- refused to sign a informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaichun Wulead
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Wu Kaichun, phD
Xijing Hospital of Digestive Diseases
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- President of Xijing Hospital of Digestive Diseases
Study Record Dates
First Submitted
August 20, 2016
First Posted
September 2, 2016
Study Start
January 1, 2014
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
February 7, 2017
Record last verified: 2017-02